Gwan Hee Han
Overview
Explore the profile of Gwan Hee Han including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shim S, Lee J, Lee Y, Park J, Lee Y, Kim S, et al.
J Gynecol Oncol
. 2024 Feb;
35(2):e66.
PMID: 38330382
In the 2023 series, we summarized the major clinical research advances in gynecologic oncology based on communications at the conference of Asian Society of Gynecologic Oncology Review Course. The review...
12.
Song J, Chun K, Han G, Yang S, Yoon S, Yuk J, et al.
Front Cardiovasc Med
. 2023 Nov;
10:1263662.
PMID: 38028493
Background: Venous thrombosis associated with the use of oral contraceptives (OCs) occurs mostly in the deep veins of the lower extremity. A lesion of the upper extremity is rare, and...
13.
Han G, Yun H, Chung J, Kim J, Cho H
Oncol Rep
. 2023 Mar;
49(5).
PMID: 36999629
The vacuolar ATPase H+ transporting V1 subunit B1 (ATP6V1B1) belongs to the family of ATP6Vs, which functions to transport hydrogen ions. The expression of ATP6V1B1 and associated clinicopathological features have...
14.
Ryu J, Shin H, Kim H, Han G, Kim J, Lee H, et al.
Front Oncol
. 2023 Mar;
13:1104521.
PMID: 36969037
Hormones may be key factors driving cancer development, and epidemiological findings suggest that steroid hormones play a crucial role in ovarian tumorigenesis. We demonstrated that high glucocorticoid receptor (GR) expression...
15.
Han G, Yun H, Chung J, Kim J, Cho H
Cancer Genomics Proteomics
. 2022 Oct;
19(6):692-702.
PMID: 36316042
Background: Transmembrane emp24 domain-containing protein 9 (TMED9) belongs to the TMED/p24 family that transports, modifies, and packs proteins and lipids into vesicles for delivery to specific locations and is important...
16.
Han G, Shim J, Yun H, Kim J, Kim J, Cho H
J Gene Med
. 2022 Sep;
24(11):e3452.
PMID: 36170157
Background: Failure to respond to treatment in epithelial ovarian cancer can often be attributed to platinum-based chemotherapy resistance. However, the possible mechanisms or candidate biomarkers associated with platinum resistance are...
17.
Yun H, Han G, Kim J, Chung J, Kim J, Cho H
J Cell Mol Med
. 2022 Sep;
26(20):5277-5291.
PMID: 36114703
NANOG engages with tumour initiation and metastasis by regulating the epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer (EOC). However, its role in association with pAMPKα, and its clinical significance in...
18.
Han G, Yun H, Kim J, Chung J, Kim J, Cho H
Am J Cancer Res
. 2022 Aug;
12(7):3437-3454.
PMID: 35968326
Glucocorticoid receptor (GR) is activated by synthetic glucocorticoid or endogenous cortisol which were released by the physical and psychosocial stress, and recent studies reported that it is involved in tumor...
19.
Kim H, Kim H, Yeo M, Won K, Kim Y, Han G, et al.
Cancer Genomics Proteomics
. 2022 Jun;
19(4):526-539.
PMID: 35732320
Background/aim: Uterine mesonephric-like adenocarcinoma (MLA) is a rare malignant tumor of the female genital tract. Patients And Methods: We reviewed 237 endometrial carcinoma cases and investigated the clinicopathological and molecular...
20.
Han G, Kim J, Yun H, Cho H, Chung J, Kim J, et al.
Cancer Genomics Proteomics
. 2021 Oct;
18(6):699-713.
PMID: 34697063
Background/aim: Cryptochrome 1 (CRY1), a core circadian gene, modulates circadian rhythm and carcinogenesis. Here, we investigated the role of CRY1 and its correlation with NANOG, a stem cell transcription factor,...